Why Canopy Growth Corp (TSX:WEED) Is Still Top of the Class

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) keeps racking up wins in the marijuana industry. How long can the company keep going?

| More on:
Gold medal

Image source: Getty Images.

Canopy Growth (TSX:WEED)(NYSE:CGC) has been one of the biggest winners of the recent explosion of the cannabis market. The company’s share price has increased at a dizzying pace over the past five years.

Canopy is now the biggest pot company in the world by market cap, and with a high production capacity, about 30% of the domestic market share, and strong international operations, it is hard to bet against the marijuana giant. Canopy recently made several moves that are likely to keep investors’ enthusiasm high. Let’s see what the Ontario-based pot grower has been up to.

Updated guidance

Canopy made headlines last week during the GMP Securities cannabis conference in Toronto. The CEO of the company — Bruce Lipton — announced the acquisition of the Spanish cannabis company Cafina. This acquisition bolsters Canopy’s international presence, which is already very strong compared to that of most of its peers. But that wasn’t it for Canopy.

The company also announced an updated guidance that left investors licking their fingers. According to the CEO, Canopy expects at least $744 million in revenues during the current fiscal year, which is much higher than most analysts’ estimates.

While the company likely won’t be profitable yet, choosing to continue aggressively pursuing expansion projects, Canopy’s revenue is a strong indication of its current place in the cannabis industry. During the last quarter, the Ontario-based firm was second to none in terms of sales, beating its closest rival by about $30 million.

Another acquisition

Canopy made yet another move last week. The company is reportedly on the verge of acquiring Acreage Holdings, one of the largest vertically integrated cannabis company in the U.S. Despite marijuana still being illegal at the federal level south of the border, the U.S. is the largest cannabis market in the world.

While the hemp market suddenly became more attractive last year once legislation was passed that made it legal (and Canopy plans on entering said market via a licence it acquired in New York), acquiring a well-established cannabis company operating in the U.S. would be an even better way for Canopy to dip its toes in the water. Shares of Canopy jumped by as much as 10% on the heels of its potential deal with Acreage Holdings.

Should you buy?

Canopy looks increasingly likely to be the dominant force in the marijuana market for years to come. In addition to its strong domestic and international operations and high production capacity, the company is now looking to enter the U.S. market in a big way. If this deal pans out, Canopy’s share value will likely reach new heights.

Let’s not forget the firm’s secret weapon: boatloads of cash to fund its growth via its partnership with Constellation Brands. Unlike some of its competitors, Canopy no longer has to rely on dilutive forms of financing to expand its production capacity or make new acquisitions. Canopy is already up by more than 50% this year. There is likely more coming, and now may be a good time to jump on the bandwagon.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the companies mentioned. 

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »